Current studies, actively enrolling.
Every study below is IRB-approved, investigator-led, and conducted at our Orange City, FL site. Study care and investigational medication are provided at no cost to participants; compensation is provided for time and travel.
Find your study in a couple quick questions.
What are you looking to address?
Type 2 Diabetes with Obesity
Evaluating a new investigational therapy for adults with Type 2 Diabetes and obesity — measuring weight loss, metabolic health, and glycemic control.
COPD with Type 2 Inflammation
Testing Depemokimab — an investigational long-acting anti–IL-5 therapy — to reduce exacerbations in adults with moderate-to-severe COPD.
Idiopathic Short Stature (ISS) Growth Study
Evaluating Vosoritide, an investigational therapy designed to support bone growth and improve height outcomes in children with Idiopathic Short Stature.
Major Depressive Disorder — Relapse Prevention
Testing Brenipatide alongside standard antidepressant therapy to delay or prevent relapse in adults currently in remission from MDD.
Adults Living with Obesity (Without Diabetes)
Clinical research evaluating weight management for adults living with obesity who do not have a diabetes diagnosis.
Type 2 Diabetes with Overweight or Obesity (VESPER-5)
A Phase 3 study (VESPER-5) of an investigational ultra-long-acting GLP-1 receptor agonist for adults with overweight or obesity and Type 2 Diabetes.
Type 2 Diabetes with Obesity (AMAZE 8)
An investigational treatment study (AMAZE 8) for adults living with Type 2 Diabetes and overweight or obesity.
Tardive Dyskinesia
A clinical research study of an investigational treatment for adults with tardive dyskinesia — involuntary, repetitive movements often linked to long-term use of certain psychiatric medications.
Tardive Dyskinesia — Valbenazine Study
A Phase 4, open-label study of valbenazine for adults with tardive dyskinesia who remain symptomatic on deutetrabenazine or after stopping a prior VMAT2 inhibitor.
COPD — New Study Coming Soon
An upcoming clinical research study for adults with COPD. Enrollment has not opened yet — join the interest list to be contacted first.
Type 2 Diabetes — New Study Coming Soon
An upcoming Type 2 Diabetes research study (REIMAGINE SWITCH). Enrollment has not opened yet — join the interest list to be contacted first.
Obesity — New Study Coming Soon
An upcoming obesity research study. Enrollment has not opened yet — join the interest list to be contacted first.